Novocardia
Latest round
- Series A
Last raised
- Jun 2021
Total raised
- $54M
Investors
- 1
About Novocardia
Founded in 2020 in Waltham, US, Novocardia focuses on innovative cardiovascular health strategies. The company was recently acquired by Cardiovascular Associates of America, enabling it to expand its reach across eight US states. The founder's details are currently unavailable.Novocardia offers a comprehensive value-based care model designed specifically for the management of cardiovascular health. Central to their offerings is the optimization of clinical efficiency through enhanced access to timely, high-quality, and affordable cardiovascular care. This model addresses the urgent need for improved patient outcomes by reducing avoidable hospitalizations and emergency room visits, particularly for patients with chronic cardiovascular diseases. Targeted primarily at primary care groups and payers, Novocardia collaborates with a wide client base, including Humana Medicare Advantage Plan members through its partnership with Cardiovascular Associates of America. The service extends across multiple states, ensuring that patients benefit from specialized services and enhanced care coordination.Novocardia generates revenue through its partnerships and value-based care agreements, most notably with entities like Humana. The revenue model relies on collaborative arrangements where shared performance data drives improvements in care quality and cost efficiency. Transactions typically occur through partnerships with healthcare providers, focusing on outcomes-based reimbursement rather than traditional fee-for-service models. These collaborations allow Novocardia to deliver specialized cardiovascular care while managing chronic conditions, ultimately leading to cost savings for clients.Following its acquisition in April 2023, Novocardia plans to enhance its cardiovascular care models and broaden its services across eight US states. Specific new products are currently in the design phase, with targeted launches as the company scales its operational capacity.
Who invested in Novocardia
1 investor across 1 round
See all investors in Novocardia
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 28, 2021
Amount
$54M
Investors
Questions about Novocardia
Who invested in Novocardia?
Novocardia has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Novocardia raised?
Novocardia has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Novocardia last raise money?
Novocardia's most recent round on record is a Series A, in Jun 2021.
What does Novocardia do?
Founded in 2020 in Waltham, US, Novocardia focuses on innovative cardiovascular health strategies.
Where is Novocardia headquartered?
Novocardia is headquartered in Waltham, US.
Which VCs invest in companies like Novocardia?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare specialists companies at Novocardia's stage. Their profiles are linked below.
VCs backing healthcare specialists startups at Series A
Raising like Novocardia? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.